Market Overview:
The global cerebrovascular disease market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of cerebrovascular diseases, rising geriatric population, and technological advancements in the field of cerebrovascular diseases. However, the high cost associated with treatment and lack of awareness about cerebrovascular diseases are some factors that are restraining the growth of this market. Based on type, the global cerebrovascular disease market is segmented into carotid endarterectomy, carotid angioplasty or carotid artery stenting, and drug medication (aspirin, ticlopidine, and sulfinpyrazone). Carotid endarterectomy is further sub-segmented into open surgery and percutaneous transluminal angioplasty (PTA). Carotid angioplasty or carotid artery stenting is further sub-segmented into balloon angioplasty and stenting.
Product Definition:
Cerebrovascular disease is a group of disorders that affect the blood vessels in the brain. These disorders can lead to a stroke, which is a sudden loss of brain function due to damage to the brain's blood vessels.
Carotid Endarterectomy:
Carotid Endarterectomy (CEA) is a surgical procedure that removes the blood clot from the carotid artery. The treatment of choice for an blocked carotid artery, which is usually caused by an injury to the brain or neck, or as a result of chronic disease such as diabetes. It helps in decreasing the pressure in the head and allows better oxygen supply to tissues.
Carotid Angioplasty Or Carotid Artery Stenting:
Carotid angioplasty or carotid artery stenting is a minimally invasive procedure used to treat carotid artery stenosis, which is caused by the buildup of plaque in the carotid artery.
Application Insights:
Based on application, the global market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, contract research organizations (CROs), others. The academic and research institutes segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high prevalence of cerebrovascular diseases coupled with rising awareness about early diagnosis among patients at risk for developing this disease. Moreover, government initiatives such as stroke care units at major medical institutions are expected to drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of stroke and cerebrovascular diseases, increasing healthcare expenditure, presence of well-established healthcare facilities, and availability of highly skilled neurosurgeons/ vascular surgeons. In addition, favorable reimbursement policies for endovascular procedures are also expected to drive growth during the forecast period.
Key players operating in this space include Medtronic plc., Boston Scientific Corporation, Abbott Laboratories Inc., Stryker Corporation; Siemens Healthineers AG; Johnson & Johnson Services LLC.; Philips Healthcare Belgium NVBA BVBA); And Novartis AG (former Novo Nordisk A/S).
Growth Factors:
- Increasing incidence of stroke due to the aging population
- Rising prevalence of risk factors such as obesity, hypertension, and diabetes
- Growing demand for minimally invasive treatments
- Advances in medical technology and surgical procedures
- increasing public awareness about cerebrovascular diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Cerebrovascular Disease Market Research Report
By Type
Carotid Endarterectomy, Carotid Angioplasty Or Carotid Artery Stenting, Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
By Application
Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Contract Research Organizations, Others
By Companies
Johnson & Johnson, Amgen, GlaxoSmithKline, Sanofi-Aventis, Merck, Sangamo BioSciences, Aldagen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Cerebrovascular Disease Market Report Segments:
The global Cerebrovascular Disease market is segmented on the basis of:
Types
Carotid Endarterectomy, Carotid Angioplasty Or Carotid Artery Stenting, Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Contract Research Organizations, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Amgen
- GlaxoSmithKline
- Sanofi-Aventis
- Merck
- Sangamo BioSciences
- Aldagen
Highlights of The Cerebrovascular Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Carotid Endarterectomy
- Carotid Angioplasty Or Carotid Artery Stenting
- Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
- By Application:
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Centers
- Contract Research Organizations
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cerebrovascular Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cerebrovascular disease is a condition in which blood flow to the brain is impaired. This can be caused by a number of factors, including atherosclerosis (hardening of the arteries), stroke, and carotid artery disease. Cerebrovascular disease can lead to serious complications, including death.
Some of the major players in the cerebrovascular disease market are Johnson & Johnson, Amgen, GlaxoSmithKline, Sanofi-Aventis, Merck, Sangamo BioSciences, Aldagen.
The cerebrovascular disease market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cerebrovascular Disease Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cerebrovascular Disease Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cerebrovascular Disease Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cerebrovascular Disease Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cerebrovascular Disease Market Size & Forecast, 2018-2028
4.5.1 Cerebrovascular Disease Market Size and Y-o-Y Growth
4.5.2 Cerebrovascular Disease Market Absolute $ Opportunity
Chapter 5 Global Cerebrovascular Disease Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cerebrovascular Disease Market Size Forecast by Type
5.2.1 Carotid Endarterectomy
5.2.2 Carotid Angioplasty Or Carotid Artery Stenting
5.2.3 Drug Medication (Aspirin
5.2.4 Ticlopidine
5.2.5 And Sulfinpyrazone)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cerebrovascular Disease Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cerebrovascular Disease Market Size Forecast by Applications
6.2.1 Academic & Research Institutes
6.2.2 Pharmaceutical & Biotechnology Companies
6.2.3 Hospitals & Diagnostic Centers
6.2.4 Contract Research Organizations
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cerebrovascular Disease Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cerebrovascular Disease Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cerebrovascular Disease Analysis and Forecast
9.1 Introduction
9.2 North America Cerebrovascular Disease Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cerebrovascular Disease Market Size Forecast by Type
9.6.1 Carotid Endarterectomy
9.6.2 Carotid Angioplasty Or Carotid Artery Stenting
9.6.3 Drug Medication (Aspirin
9.6.4 Ticlopidine
9.6.5 And Sulfinpyrazone)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cerebrovascular Disease Market Size Forecast by Applications
9.10.1 Academic & Research Institutes
9.10.2 Pharmaceutical & Biotechnology Companies
9.10.3 Hospitals & Diagnostic Centers
9.10.4 Contract Research Organizations
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cerebrovascular Disease Analysis and Forecast
10.1 Introduction
10.2 Europe Cerebrovascular Disease Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cerebrovascular Disease Market Size Forecast by Type
10.6.1 Carotid Endarterectomy
10.6.2 Carotid Angioplasty Or Carotid Artery Stenting
10.6.3 Drug Medication (Aspirin
10.6.4 Ticlopidine
10.6.5 And Sulfinpyrazone)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cerebrovascular Disease Market Size Forecast by Applications
10.10.1 Academic & Research Institutes
10.10.2 Pharmaceutical & Biotechnology Companies
10.10.3 Hospitals & Diagnostic Centers
10.10.4 Contract Research Organizations
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cerebrovascular Disease Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cerebrovascular Disease Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cerebrovascular Disease Market Size Forecast by Type
11.6.1 Carotid Endarterectomy
11.6.2 Carotid Angioplasty Or Carotid Artery Stenting
11.6.3 Drug Medication (Aspirin
11.6.4 Ticlopidine
11.6.5 And Sulfinpyrazone)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cerebrovascular Disease Market Size Forecast by Applications
11.10.1 Academic & Research Institutes
11.10.2 Pharmaceutical & Biotechnology Companies
11.10.3 Hospitals & Diagnostic Centers
11.10.4 Contract Research Organizations
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cerebrovascular Disease Analysis and Forecast
12.1 Introduction
12.2 Latin America Cerebrovascular Disease Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cerebrovascular Disease Market Size Forecast by Type
12.6.1 Carotid Endarterectomy
12.6.2 Carotid Angioplasty Or Carotid Artery Stenting
12.6.3 Drug Medication (Aspirin
12.6.4 Ticlopidine
12.6.5 And Sulfinpyrazone)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cerebrovascular Disease Market Size Forecast by Applications
12.10.1 Academic & Research Institutes
12.10.2 Pharmaceutical & Biotechnology Companies
12.10.3 Hospitals & Diagnostic Centers
12.10.4 Contract Research Organizations
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cerebrovascular Disease Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cerebrovascular Disease Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cerebrovascular Disease Market Size Forecast by Type
13.6.1 Carotid Endarterectomy
13.6.2 Carotid Angioplasty Or Carotid Artery Stenting
13.6.3 Drug Medication (Aspirin
13.6.4 Ticlopidine
13.6.5 And Sulfinpyrazone)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cerebrovascular Disease Market Size Forecast by Applications
13.10.1 Academic & Research Institutes
13.10.2 Pharmaceutical & Biotechnology Companies
13.10.3 Hospitals & Diagnostic Centers
13.10.4 Contract Research Organizations
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cerebrovascular Disease Market: Competitive Dashboard
14.2 Global Cerebrovascular Disease Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Amgen
14.3.3 GlaxoSmithKline
14.3.4 Sanofi-Aventis
14.3.5 Merck
14.3.6 Sangamo BioSciences
14.3.7 Aldagen
